Peak HumanDatabase
    All Research
    PAPER REMNANPost hoc analysis of RCT2022

    Remnant cholesterol and its visit-to-visit variability predict cardiovascular outcomes in patients with type 2 diabetes: findings from the ACCORD cohort

    In the ACCORD cohort (type 2 diabetes), higher remnant cholesterol and greater visit-to-visit variability predicted cardiovascular events.

    Evidence

    7/10

    Moderate Evidence

    Sample

    —

    subjects

    Duration

    —

    study period

    Journal

    Diabetes Care

    Sep 2022

    02

    Key Findings

    1. 01

      Higher remnant cholesterol and its variability predicted CV events in type 2 diabetes

    03

    Structured Methods

    Study Design
    Post hoc analysis of RCT
    Sample Size
    Not reported
    Study Duration
    Not reported
    Methodology
    Not reported
    Limitations
    Not reported
    04

    Citations & References

    Cite this paper

    Unknown authors (2022). Remnant cholesterol and its visit-to-visit variability predict cardiovascular outcomes in patients with type 2 diabetes: findings from the ACCORD cohort. Diabetes Care.

    Source

    Publisher

    Journal

    Diabetes Care

    05

    Indexing

    Topics

    cardiovascular riskdiabetes

    Biomarkers

    Remnant Cholesterol
    PHS
    671
    / 1000
    T3
    Longevity Operator

    Sample member

    Longevity Operator

    The Peak Human Score · PHS v1

    One number for your longevity journey.

    FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.

    • Metabolic
    • Hormonal
    • Cardiovascular
    • Brain / Cognitive
    • Sleep
    • Musculoskeletal
    • Gut
    • Immunity / Inflammation
    See your Peak Human Score How it works